# METFORMIN FOR ATRIAL FIBRILLATION

> **NCT05878535** · PHASE2 · UNKNOWN · sponsor: **Arab Contractors Medical Centre** · enrollment: 770 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05878535
- **Lead sponsor:** Arab Contractors Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-04
- **Target enrollment:** 770 (ESTIMATED)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05878535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05878535, "METFORMIN FOR ATRIAL FIBRILLATION". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05878535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*